Preclinical studies on Molecular understanding of Hepatoprotective drug action of homoeopathic preparation of Myrica cerifera 3C and its clinical effectiveness in comparison to Individualised homoeopathic medicine in patients suffering from the Non Alcoholic Fatty Liver Disease with respect to Liver Function Test parameters: An open label Randomised Controlled Clinical Trial

Dr Raja Manoharan0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Absence of regular or excessive use of alcohol (more than 20 gram per day in men and 10 gram in female).
•History of bowel surgery, Bariatric surgery or undergoing evaluation for bariatric surgery
•for obesity, extensive small bowel resection or orthotopic liver transplants.
•History of other chronic liver disease (Viral hepatitis B or C, autoimmune hepatitis, Cholestatic and metabolic liver diseases) and hemochromatosis.
•Known case of cirrhosis
•Patients with Hypothyroidism
•History of myopathies or evidence of active muscle disease.
•History of bladder disease and /or haematuria or has haematuria except due to UTI.
•Pregnant women, Lactating women & paediatric age group ( < 18yrs)
•Uncontrolled Diabetes, Hypertension, Mental illness or depression, kidney or heart disease, Malignant conditions as well as with history of stroke.
•Person under corticosteroid therapy.
•Patients who are too sick for consultation and not willing to cooperate
•Unwilling to take part and not giving consent to join the study

发起方

Dr Raja Manoharan